Last10K.com

Allakos Inc. (ALLK) SEC Filing 8-K Material Event for the period ending Thursday, March 31, 2022

Allakos Inc.

HISTORY TOOLS
CIK: 1564824 Ticker: ALLK

View differences made from one to another to evaluate Allakos Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Allakos Inc..

Continue

Assess how Allakos Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Allakos Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 8-K Corporate News

Document And Entity Information
Ticker: ALLK
CIK: 1564824
Form Type: 8-K Corporate News
Accession Number: 0000950170-22-005374
Submitted to the SEC: Tue Apr 05 2022 4:30:53 PM EST
Accepted by the SEC: Tue Apr 05 2022
Period: Thursday, March 31, 2022
Industry: Pharmaceutical Preparations
Events:
  1. New Agreement
  2. New Financial Obligation

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/allk/0000950170-22-005374.htm